Ishrak: Medtronic has eyes on overseas acquisitions

Medtronic ($MDT) is eyeing overseas acquisitions and has roughly $2 billion a year to spend, said Omar Ishrak at the J.P. Morgan Healthcare Conference in San Francisco, Bloomberg notes. However, "[w]e need to have a far more disciplined approach to acquisitions," said Ishrak. "That may be tough, but we'll have to find a way to do it. It's going to be a big hurdle to get any form of dilution from us." News

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.